Coronavirus Disease 2019 (COVID-19) Information for Cardiologists -Systematic Literature Review and Additional Analysis-

被引:16
|
作者
Sugimoto, Tadafumi [1 ]
Mizuno, Atsushi [2 ,3 ,4 ,21 ]
Kishi, Takuya [5 ,21 ]
Ito, Naoya [6 ]
Matsumoto, Chisa [7 ,21 ]
Fukuda, Memori [8 ,21 ]
Kagiyama, Nobuyuki [9 ]
Shibata, Tatsuhiro [10 ]
Ohmori, Takashi [11 ]
Oishi, Shogo [12 ]
Fuse, Jun [13 ]
Kida, Keisuke [14 ]
Kawai, Fujimi [15 ]
Ishida, Mari [16 ,21 ]
Sanada, Shoji [17 ,21 ]
Komuro, Issei [18 ,19 ]
Node, Koichi [19 ,20 ,21 ]
机构
[1] Mie Univ Hosp, Dept Clin Lab, Tsu, Mie, Japan
[2] St Lukes Int Hosp, Dept Cardiol, Tokyo, Japan
[3] Univ Penn, Dept Internal Med, Philadelphia, PA 19104 USA
[4] Juntendo Univ, Dept Cardiol, Tokyo, Japan
[5] Int Univ Hlth & Welf, Dept Grad Sch Med Cardiol, Okawa, Japan
[6] Shizuoka Canc Ctr Hosp, Div Infect Dis, Shizuoka, Japan
[7] Tokyo Med Univ, Ctr Hlth Surveillance & Prevent Med, Dept Cardiol, Tokyo, Japan
[8] Keio Univ Hosp, Dept Cardiol, Tokyo, Japan
[9] West Virginia Univ, Heart & Vasc Inst, Morgantown, WV 26506 USA
[10] Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Kurume, Fukuoka, Japan
[11] Iizuka Hosp, Dept Transit Med & Palliaitve Care, Iizuka, Fukuoka, Japan
[12] Himeji Cardiovasc Ctr, Dept Cardiol, Himeji, Hyogo, Japan
[13] Well Being Clin Komazawa Pk, Tokyo, Japan
[14] St Marianna Univ, Sch Med, Dept Pharmacol, Kawasaki, Kanagawa, Japan
[15] St Lukes Int Univ Lib, Tokyo, Japan
[16] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Physiol & Med, Hiroshima, Japan
[17] Osaka City Univ Hosp, Ctr Clin Res & Innovat, Osaka, Japan
[18] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan
[19] Japanese Circulat Soc, Execut Comm, Tokyo, Japan
[20] Saga Univ, Dept Cardiovasc Med, Saga, Japan
[21] Japanese Circulat Soc, Informat & Commun Comm, Tokyo, Japan
关键词
Cardiologist; COVID-19; Heart failure; Infection; Myocardial injury;
D O I
10.1253/circj.CJ-20-0302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite the rapidly increasing attention being given to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, more commonly known as coronavirus disease 2019 (COVID-19), the relationship between cardiovascular disease and COVID-19 has not been fully described. Methods and Results: A systematic review was undertaken to summarize the important aspects of COVID-19 for cardiologists. Protection both for patients and healthcare providers, indication for treatments, collaboration with other departments and hospitals, and regular update of information are essentials to front COVID-19 patients. Conclusions: Because the chief manifestations of COVID-19 infection are respiratory and acute respiratory distress syndrome, cardiologists do not see infected patients directly. Cardiologists need to be better prepared regarding standard disinfection procedures, and be aware of the indications for extracorporeal membrane oxygenation and its use in the critical care setting.
引用
收藏
页码:1039 / +
页数:15
相关论文
共 50 条
  • [31] Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis
    Huang, Ian
    Pranata, Raymond
    JOURNAL OF INTENSIVE CARE, 2020, 8 (01)
  • [32] Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19)
    Chong-xiang Chen
    Fang Hu
    Jin Wei
    Le-tao Yuan
    Tian-meng Wen
    Robert Peter Gale
    Yang Liang
    Leukemia, 2021, 35 : 1661 - 1670
  • [33] Coronavirus Disease 2019 (Covid-19) and Prevalence of Olfactory Dysfunction: Systematic Review and Meta-Analysis
    Badran, Aly Mohammed
    Alqurashi, Ahmed Mahmoud
    Aljabarah, Norah Sulaiman
    Althobaiti, Turki Abdulmuin
    Alrayyes, Nouf Fahad
    Alharbi, Joud Fahad
    ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH, 2021, 11 : 1 - 4
  • [34] Coronavirus disease 2019 (COVID-19) related cytopenia A protocol for systematic review and meta-analysis
    Li, Yiwei
    Weng, Qianping
    Huang, Xilian
    Xie, Yaping
    Chen, Can
    Qian, Shenxian
    MEDICINE, 2020, 99 (36) : E22033
  • [35] Ocular surface manifestations of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
    Aggarwal, Kanika
    Agarwal, Aniruddha
    Jaiswal, Nishant
    Dahiya, Neha
    Ahuja, Alka
    Mahajan, Sarakshi
    Tong, Louis
    Duggal, Mona
    Singh, Meenu
    Agrawal, Rupesh
    Gupta, Vishali
    PLOS ONE, 2020, 15 (11):
  • [36] Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis
    Yassin, Ahmed
    Nawaiseh, Mohammed
    Shaban, Ala
    Alsherbini, Khalid
    El-Salem, Khalid
    Soudah, Ola
    Abu-Rub, Mohammad
    BMC NEUROLOGY, 2021, 21 (01)
  • [37] Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19)
    Chen, Chong-xiang
    Hu, Fang
    Wei, Jin
    Yuan, Le-tao
    Wen, Tian-meng
    Gale, Robert Peter
    Liang, Yang
    LEUKEMIA, 2021, 35 (06) : 1661 - 1670
  • [38] Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis
    Fu, Leiwen
    Wang, Bingyi
    Yuan, Tanwei
    Chen, Xiaoting
    Ao, Yunlong
    Fitzpatrick, Thomas
    Li, Peiyang
    Zhou, Yiguo
    Lin, Yi-fan
    Duan, Qibin
    Luo, Ganfeng
    Fan, Song
    Lu, Yong
    Feng, Anping
    Zhan, Yuewei
    Liang, Bowen
    Cai, Weiping
    Zhang, Lin
    Du, Xiangjun
    Li, Linghua
    Shu, Yuelong
    Zou, Huachun
    JOURNAL OF INFECTION, 2020, 80 (06) : 656 - 665
  • [39] Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis
    Ian Huang
    Raymond Pranata
    Journal of Intensive Care, 8
  • [40] Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
    Huang, Dong
    Yu, He
    Wang, Ting
    Yang, Huan
    Yao, Rong
    Liang, Zongan
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) : 481 - 490